New Delhi, March 13 (IANS) Pakistan is facing a serious shortage of essential medicines as the ongoing conflict in the Middle East disrupts the import of pharmaceutical raw materials and other critical supplies, according to a new report.The neighbour nation’s existing stock of pharmaceutical raw materials is sufficient for only about one-and-a-half months, according to the report in The Express Tribune.The conflict involving Iran, Israel and the United States has led to the suspension of seve…
Latest pharmaceutical industry News & Updates
New Delhi, March 2 (IANS) India’s active pharmaceutical ingredient (API) market, currently valued at about $15–16 billion, is projected to grow at a compound annual growth rate of 5–7 per cent in FY27 and FY28, a report said on Monday.The report from CareEdge Ratings said the growth will be driven by favourable government policies, a structural shift toward high‑potency and complex APIs, rising domestic demand and deeper penetration into regulated and emerging markets.Indian pharma firms…
Washington, Feb 7 (IANS) Two US senators from rival parties introduced legislation this week that would require prescription drug labels to disclose where medicines and their key ingredients are made, a move aimed at increasing transparency in a supply chain heavily reliant on overseas manufacturing.US Senators Seek Drug Origin Democratic Senator Kirsten Gillibrand and Republican Senator Rick Scott said the proposal would help patients, pharmacists and doctors better understand the origins of th…
New Delhi, Jan 28 (IANS) Union Ministry of Health and Family Welfare on Tuesday notified key amendments to the New Drugs and Clinical Trials (NDCT) Rules, 2019, which will help reduce drug development timelines, as well as strengthen the clinical research and pharmaceutical development ecosystem.The amendments are aimed at simplifying regulatory processes, reducing approval timelines, and promoting ease of doing business.The regulatory reforms will provide substantial benefits to stakeholders wh…
Vapi, Jan 23 (IANS) Industries in Gujarat’s Vapi district, which earn crores of rupees in foreign exchange through exports, are currently going through a difficult phase due to the Trump-led US administration’s tariffs on Indian products. In such a scenario, there are expectations that the Union Budget presented by the Central government this time will provide relief to the local industries in the state. In the coming days, the Central government will present the Union Budget on February 1 this …
New Delhi, Jan 13 (IANS) There will not be any material impact on credit profiles of Indian corporates engaged in business with Venezuelan customers, given their modest exposure, a report said on Tuesday.Crisil Ratings does not expect the recent developments in Venezuela to have any material impact on India’s global trade or the credit quality of Indian corporates.“Even in the event of any escalation that disrupts crude oil production in Venezuela, the country’s relatively small share (1.5…
Seoul, Jan 13 (IANS) Around 40 per cent of South Korean manufacturers expect economic conditions to deteriorate this year amid increased volatility in the foreign exchange (FX) market, a poll showed on Tuesday.According to the poll conducted recently by the Korea Chamber of Commerce and Industry (KCCI) on 2,208 manufacturing firms, a total of 40.1 percent of respondents said they expect a deterioration in economic conditions, reports Yonhap news agency.In detail, 14.7 per cent of respondents poi…
New Delhi, Dec 25 (IANS)With GST reforms and Research Development Incentive (RDI) Scheme, the year 2025 has been a crucial turning point for Indian pharma, said industry experts on Thursday, while highlighting innovation and increased access as key factors for the sector’s growth in 2026.Indian pharma is standing at a defining moment. In the past 25 years, the industry has grown from $3 billion to $60 billion. The next 25 years will be shaped by innovation, quality, and access.“The year 2025…
New Delhi, Dec 25 (IANS) Sun Pharma’s US arm, Taro Pharmaceutical Industries, has recalled more than 17,000 units of antifungal over manufacturing issues, the US Food and Drug Administration (USFDA) has said.The Ciclopirox Shampoo — an antifungal medication that treats seborrheic dermatitis (a condition that causes dry, flaky, and itchy skin) — is being recalled due to “failed impurity/degradation specifications”, the USFDA said, in its latest Enforcement Report.The Class II nationwide r…